ReviewJournal of the American College of Cardiology2017

Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.

Peter LibbyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.